Article Details
Retrieved on: 2017-12-18 04:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Emerging technologies</b> remain of interest. CAR-T therapy , which trains a patient's immune cells to fight cancer, and precision oncology had a strong 2017. But success in immuno-oncology combinations, cancer vaccines and certain antibodies has only been modest. "We think next-generation ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here